Livzon Pharmaceutical Group Inc.’s Net Profit Rose 5.1% in First Half of 2023

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 1.2 billion yuan in the first half of 2023, up 5.1% year-on-year.

Meanwhile, the company posted 6.7 billion yuan in revenue, up 6.1% year-on-year.

At the end of the reporting period, it had 25.7 billion yuan in total assets and 11.5 billion yuan in total liabilities, with a liability-to-asset ratio of 44.6%.